Omara, D; Ndekezi, C; Mugaba, S; Nakyanzi, A; Bukenya, H; Bwogi, J; Natwijuka, F; KAPAATA, A; KATO, F; Byamukama, D; Ayebale, ML; Kateete, DP; SERWANGA, J; COSE, S; Obondo, SJ; KALEEBU, P; BALINDA, SN;

Makusha, T; Ngubo, Z; SEELEY, J; Archary, M;

Sevene, E; Maculuve, S; Tchavana, C; Valá, A; Quimice, L; Macuacua, S; Carrilho, C; Gonzalez, R; Nhampossa, T; Menendez, C; Craik, R; Hookham, L; Le Doare, K; Von Dadelszen, P; PeriCOVID-Africa and PRECISE Network,;

Khalid, A; Gettins, L; Scullion, L; Liu, X; Lin Wei, LL; Masai, AN; Guerin, PJ; Allel, K; Hemelaar, J; Global HIV Molecular Epidemiology Collaboration,;

Walusimbi, B; Natukunda, A; Amongin, R; Heyraud, V; Baine, C; Nassuuna, J; WEBB, EL; ELLIOTT, AM; NKURUNUNGI, G;

KAWUMA, R; Nakamanya, S; Tarimo, E; Chimukuche, RS; Ambindwile, J; Pamba, D; KUSEMERERWA, S; Munseri, P; Singh, N; Dubé, K; McCormack, S; RUZAGIRA, E; SEELEY, J; PrEPVacc trial team,;

Mabuto, T; Orievulu, K; BOND, V; Simwinga, M; Grapsa, E; Khoza, T; Khan-Gillmore, S; Nzimande, L; Craig, M; Khagayi, S; Chirwa, T; Chiau, R; Ossemane, E; Hoffmann, C; SEELEY, J; Kniveton, D; Babashahi, S; Rangunwala, A; Mthembu, N; Oberholzer, C; Charalambous, S; Iwuji, C;

KUSEMERERWA, S; Kansiime, S; MUTONYI, G; KAKANDE, A; Nabukenya, S; Namirembe, A; Erima, N; Asio, DJ; Atuhura, EM; Ssendagire, S; Onyango, M; Fox, J; McCormack, S; KALEEBU, P; RUZAGIRA, E; PrEPVacc Study Team,;

Stuart, AS; Muhumuza, R; KUSEMERERWA, S; Ndagire, MT; Hill, M; O'Reilly, PJ; Onyango, M; Solomon, W; Akankunda, P; Masawi, S; Ssendagire, S; Murphy, D; Vanderslott, S; Rollier, CS; RUZAGIRA, E; Pollard, AJ; KYEGOMBE, N;

MAYANJA, Y;